CHF患者血清CgA、leptin和ADPN水平变化及其与心功能的相关性分析

doi:10.3969/j.issn.1671-7171.2019.04.014

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the changes of serum chromogranin (CgA), leptin and adiponectin (ADPN) in patients with chronic heart failure (CHF) and their relationship with cardiac function. 【Methods】A total of 110 patients with CHF (the CHF group) and 110 healthy subjects (the control group) were enrolled in our hospital from April 2016 to September 2017. Serum CgA, leptin and adiponectin levels were measured in all patients of the two groups. The New York Heart Association (NYHA) grading standards were used to analyze the correlation between serum CgA, leptin and adiponectin levels and cardiac function indicators. 【Results】Serum levels of CgA, leptin and adiponectin were significantly higher in the CHF group than in the control group (P<0.05). The LVEF of the CHF group was lower than that of the control group (P<0.05). The values of LVEDD, LAD, RVD and LVMI were higher than those of the control group (P<0.05). The levels of serum CgA, leptin and ADPN in NYHA class Ⅱ,Ⅲ and Ⅳ patients with CHF were gradually increased, and the differences were statistically significant (P<0.05). Serum levels of CgA, leptin and ADPN in the CHF group were significantly negatively correlated with LVEF (r_CgA=-0.721, r_leptin=-0.693,r_ADPN=-0.580, both P<0.05).【Conclusion】The levels of serum CgA, leptin and adiponectin in patients with CHF increase significantly and show negative correlation with LVEF indicating the deterioration of cardiac function in patients.

Key words： Heart Failure Chromogranins Leptin

Received: 13 September 2018

PACS:

R541.61

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DING Wei
	CHEN Wen-zhong

Cite this article:

DING Wei,CHEN Wen-zhong. Changes in Serum CgA, Leptin and Adiponectin Levels and Correlation with Cardiac Function in Chronic Heart Failure Patients[J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(4): 664-666.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2019.04.014 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2019/V36/I4/664

[1] 赵艳辉,丛洪良. 心衰患者血清胱抑素C、嗜铬粒蛋白A与心室重构的关系[J].天津医科大学学报,2015,21(03):193-195.
[2] 张昕,石翠翠. 心力衰竭合并恶病质大鼠瘦素及Janus蛋白酪氨酸激酶2/信号传导与转录激活因子3信号转导通路的变化[J].中国循环杂志,2016,31(1):82-86.
[3] 张金龙,洪小苏,陈艳红. 脂联素水平对慢性心力衰竭患者近期预后的预测价值[J].中国医师杂志,2015,17(11):1704-1706.
[4] Zaidi SS, Ward RD, Ramanathan K,et al. Possible enzymatic downregulation of the natriuretic peptide system in patients with reduced systolic function and heart failure: a pilot study[J].Biomed Res Inter,2018,28(8):1-6.
[5] Goyal H, Lippi G, Hu Z. B-Natriuretic peptide in prognosis of patients with or without heart?failure[J].J Am Coll Cardiol,2018,72(10):1179-1180.
[6] 杨秀丽,刘迎春,冉倩,等. 辛伐他汀对慢性心力衰竭幼兔心肌嗜铬粒蛋白A、细胞凋亡信号调节激酶1表达的影响[J].中华实用儿科临床杂志,2017,32(5):365-368.
[7] 石翠翠,张昕. 瘦素和瘦素基因G-2548A多态性与心力衰竭恶病质发生的相关性[J].中华临床医师杂志(电子版),2015,9(9):1509-1513.
[8] 徐洁,骆小梅,张颖. 慢性心力衰竭患者血清脂联素水平与心功能及左室重构的相关性[J].中国老年学杂志,2017,37(1):91-93.
[9] 晏平,郭敏军,李惠玲,等. 慢性心力衰竭患者血清Lp-PLA2、CgA水平与心室重构的关系[J].山东医药,2018,58(20):88-90.
[10] 梅艳,郗爱旗,廖宝霞,等. 低氧环境下慢性充血性心力衰竭患者脂肪因子水平变化对心室构型的影响[J].第三军医大学学报,2017,39(23):2299-2302.
[11] 陈伟. 内脂素与脂联素在急性心肌梗死经皮冠状动脉介入术后发生心力衰竭中的意义[J].中国循证心血管医学杂志,2015,7(3):365-367.
[12] 王梦龙,刘剑芳,刘梦林,等. 瘦素在心衰患者心肌中的表达及其与心肌炎症反应的相关性[J].海南医学,2015,26(14):2040-2042.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(5): 990-991.